benzylidene glucose has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aastveit, TE; Dornish, JM; Dunsaed, CB; Nesland, JM; Pettersen, EO | 1 |
| Furuno, T; Kagamimori, S; Kitagawa, M; Komori, Y; Koyama, S; Sato, H; Tatsumura, T; Tsujimoto, M; Yamamoto, K | 1 |
2 other study(ies) available for benzylidene glucose and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013).
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma; Female; Glucose; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Ovarian Neoplasms; Pancreatic Neoplasms; Transplantation, Heterologous | 1995 |
4, 6-0-benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, an extended phase I study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Child; Colonic Neoplasms; Drug Evaluation; Female; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Prostatic Neoplasms; Stomach Neoplasms | 1990 |